Magnetic Resonance of Body, Arterial Wall, and Angiography Imaging for Non- Invasive Assessment of Arterial Distensibility, Endothelial Dysfunction and Atherosclerotic Disease Using 1.5T and High Field (3T) MRI: A Technical Development Study of Cardiac and Body Imaging

  • End date
    Nov 5, 2030
  • participants needed
  • sponsor
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Updated on 25 October 2022
cardiovascular disease
ct scan
metabolic syndrome
diabetes mellitus
heart disease
blood test
Accepts healthy volunteers


  • Imaging tests, such as magnetic resonance imaging (MRI), can provide information about heart and blood vessels. The tests let doctors can see the amount of blood vessel narrowing and vessel wall thickness. This information may help diagnose and treat heart disease and other conditions that lead to heart attacks. Better MRI methods are needed to improve heart disease diagnosis, especially by avoiding the use of radiation. Researchers are testing new techniques to improve the quality of heart MRI, compared with more complex studies like catheterization or angiography.
  • To compare heart MRI techniques with other tests used to diagnose heart disease.
  • People at least 18 years of age who either have or may have heart disease, or are healthy volunteers.
  • Participants will be screened with a physical exam, medical history, and blood tests.
  • They will have an angiography to study the inside of blood vessels. This test is an x-ray study of the blood vessels. It will be done either separately or as part of a set of tests to diagnose possible heart disease.
  • Participants will have at least one and up to five MRI scans. The scans will involve different methods of studying the heart and blood vessels. Participants may also have a computed tomography scan to confirm the findings of an MRI scan.
  • No treatment will be provided as part of this protocol.


Specialized imaging techniques now available allow a unique opportunity to characterize the micro-environment of the human body. Magnetic Resonance (MR) vascular wall imaging and angiography (MRA) are developing techniques that permit non-invasive evaluation of arterial and venous structures without the need for x-ray based catheter angiography. In addition, vessel wall imaging provides unprecedented non-invasive tools to assess vascular endothelial function. While dramatic progress has been made to cardiovascular MR imaging in the last few years, there are still substantial limitations in the resolution, accuracy, and reproducibility of MRA and wall imaging in the comprehensive structural and functional evaluation of coronary artery. The first aim of this study is to develop and optimize clinical imaging protocols and techniques for fast high-resolution coronary MRA and wall imaging for the assessment of coronary and other main arteries structural, distensibility, and endothelial functional parameters. Technique optimization and performance evaluation will be accomplished in normal subjects without known or suspected coronary atherosclerosis. The second aim of this protocol is to evaluate early MR imagery signs of arterial structural, distensibility, and endothelial functional disorders associated with atherosclerosis in a cohort of patients with known or suspected coronary atherosclerosis. Results from accelerated high-resolution MRA will be correlated with corresponding Computerized Tomography Coronary Angiogram (CTA) results. The third aim of this protocol is to develop, implement, and optimize new non-invasive methods for characterization of the micro-environment in the thoracic and abdominal area utilizing specialized techniques such as MR Spectroscopy, MR Elastography, and blood oxygenation level dependent (BOLD) imaging. The long-term objective of this study and research initiative is to optimize coronary MRA, wall, and body imaging techniques to the point that it can reliably be used for routine prevention and assessment of early atherosclerosis and other diseases.

Condition Healthy, Obesity, Diabetes, Healthy Volunteers, Atherosclerosis
Treatment MR Imagining Techniques, MR Imaging Techniques - 1, MR Imaging Techniques - 2, MR Imaging Techniques - 3, MR Imaging Techniques - 4
Clinical Study IdentifierNCT01399385
SponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Last Modified on25 October 2022


Yes No Not Sure

Inclusion Criteria

Subjects with or without history of cardiovascular diseases and with various degrees of cardiovascular risk factor. Subjects with known or suspected atherosclerotic disease based on clinical findings or documented by angiography (conventional, CTA or MRA), or Doppler ultrasound. And, healthy volunteers and subjects with known or suspected diseases affecting the thoracic organs, abdominal organs, and other organs affected by metabolic diseases such as body fat and muscles. Subjects at risk for atherosclerosis including: smoking, obesity, hyperlipidemia, low levels of high density lipoproteins (<50 mg/dl for women and <40 mg/dl for men), hypertension, family history (early onset atherosclerosis <55 year old in male and < 65 year old in female who is first degree relative), and diabetes mellitus or metabolic syndrome
Subject must be willing to participate in the protocol
Subject age greater than 18 years old
Subject must be able to provide informed consent
Subject must be clinically stable and be able to come to the Clinical Center to participate in the study

Exclusion Criteria

Subjects with contraindication to MRI scanning. These contraindications include but are not limited to the following devices or conditions
Implanted cardiac pacemaker or defibrillator
Cochlear Implants
Ocular foreign body (e.g. metal shavings)
Embedded shrapnel fragments
Central nervous system aneurysm clips
Implanted neural stimulator
Medical infusion pumps
Any implanted device that is incompatible with MRI
Unsatisfactory performance status as judged by the referring physician such that the
Subjects requiring sedation for MRI studies
subject could not tolerate an MRI scan. Examples of medical conditions that
Subjects with a condition precluding entry into the scanner (e.g. morbid obesity, claustrophobia, etc.)
would not be accepted would include unstable angina and dyspnea at rest
Pregnant or lactating women
Subjects with severe back-pain or motion disorders who will be unable to tolerate supine positioning within the MRI scanner and hold still for the duration of the examination
Subjects who are unable to undergo a CTA within 2 months of the MRA part of this study, or are unable to undergo or be scheduled for a cardiac catheterization within 2 months of the MRA
History of allergic reaction to gadolinium contrast agents despite the use of premeditation with an anti-histaminic and cortisone
eGFR < 60 ml/min/1.73m^2
Contraindication to the use of CTA contrast agents
Creatinine value > 1.4 mg/dl
History of multiple myeloma
Use of metformin-containing products less than 24 hrs prior to contrast administration
History of allergic reaction to CTA contrast agents despite the use of premedication with an anti-histaminic and cortisone
Subjects with contraindication precluding the use of beta blockers necessary to
Active bronchospasm
Moderate or severe COPD
perform the coronary CTA. These include
2nd or 3rd degree AV block
Decompensated cardiac failure
Allergy to beta blockers
Systolic blood pressure < 100 mm Hg
Pregnancy or nursing
Subjects reporting a history of the following conditions will be excluded
Severe aortic stenosis
Hypertrophic cardiomyopathy
Inferior myocardial infarction with right ventricular involvement
Cardiac tamponade
Constrictive pericarditis
Severe hypotension (systolic BP <90 mmHg)
Uncorrected hypovolemia
Raised intracranial pressure
Severe anemia
Concomitant use of phosphodiesterase-5 inhibitors (sildenafil-Viagra, tadalifil-Cialis, verdenafil-Levitra)
History of hypersensitivity to nitroglycerin
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note